SLC7A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.918300E-02
Normal-vs-Stage2
2.711800E-01
Normal-vs-Stage3
2.775600E-01
Normal-vs-Stage4
6.622400E-02
Stage1-vs-Stage2
8.501400E-01
Stage1-vs-Stage3
1.585960E-02
Stage1-vs-Stage4
2.357600E-01
Stage2-vs-Stage3
6.793800E-02
Stage2-vs-Stage4
1.750970E-01
Stage3-vs-Stage4
1.775650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.294000E-01
Normal-vs-AfricanAmerican
2.377200E-01
Normal-vs-Asian
6.366000E-01
Caucasian-vs-AfricanAmerican
4.621000E-01
Caucasian-vs-Asian
1.940020E-01
AfricanAmerican-vs-Asian
1.034370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.588400E-01
Normal-vs-Female
3.912600E-01
Male-vs-Female
9.284800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.873900E-02
Normal-vs-Age(41-60Yrs)
2.375000E-01
Normal-vs-Age(61-80Yrs)
3.773800E-01
Normal-vs-Age(81-100Yrs)
4.188000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.494280E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.040400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.431400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.709000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.518400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.236200E-01
Normal-vs-Daily Drinker
4.684600E-01
Normal-vs-Weekly Drinker
4.981800E-01
Normal-vs-Occasional Drinker
1.975780E-02
Normal-vs-Social Drinker
1.056340E-02
Non Drinker-vs-Daily Drinker
5.074000E-01
Non Drinker-vs-Weekly Drinker
4.487200E-01
Non Drinker-vs-Occasional Drinker
4.673900E-02
Non Drinker-vs-Social Drinker
2.609800E-02
Daily Drinker-vs-Weekly Drinker
7.317400E-01
Daily Drinker-vs-Occasional Drinker
8.912000E-02
Daily Drinker-vs-Social Drinker
5.594500E-02
Weekly Drinker-vs-Occasional Drinker
1.752240E-01
Weekly Drinker-vs-Social Drinker
1.352210E-01
Occasional Drinker-vs-Social Drinker
9.735800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.522000E-01
Normal-vs-Grade 2
8.197600E-02
Normal-vs-Grade 3
3.539700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.091000E-01
Grade 1-vs-Grade 3
2.356800E-01
Grade 1-vs-Grade 4
2.522000E-01
Grade 2-vs-Grade 3
8.879800E-01
Grade 2-vs-Grade 4
8.197600E-02
Grade 3-vs-Grade 4
3.539700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.648000E-01
Normal-vs-NonDiabetic
3.737600E-01
Diabetic-vs-NonDiabetic
2.003400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.235800E-01
Normal-vs-NoPancreatitis
3.875600E-01
Pancreatitis-vs-NoPancreatitis
7.021200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.815300E-03
Normal-vs-N1
2.867800E-01
N0-vs-N1
4.927600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.980100E-04
Normal-vs-TP53-NonMutant
2.076700E-03
TP53-Mutant-vs-TP53-NonMutant
3.202400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
